Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Other Long-Term Liabilities : $0.00 Mil (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Other Long-Term Liabilities?

Parnell Pharmaceuticals Holdings's other long-term liabilities for the quarter that ended in Dec. 2018 was $0.00 Mil.

Parnell Pharmaceuticals Holdings's quarterly other long-term liabilities increased from Dec. 2016 ($-0.00 Mil) to Dec. 2017 ($-0.00 Mil) and increased from Dec. 2017 ($-0.00 Mil) to Dec. 2018 ($0.00 Mil).

Parnell Pharmaceuticals Holdings's annual other long-term liabilities increased from Dec. 2016 ($-0.00 Mil) to Dec. 2017 ($-0.00 Mil) and increased from Dec. 2017 ($-0.00 Mil) to Dec. 2018 ($0.00 Mil).

Parnell Pharmaceuticals Holdings Other Long-Term Liabilities Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Other Long-Term Liabilities Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Other Long-Term Liabilities

Get a 7-Day Free Trial

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Other Long-Term Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Parnell Pharmaceuticals Holdings Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Parnell Pharmaceuticals Holdings Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.